GlassScriptPhysician profile
Douglas P Peller
NPI 1083754600
$2,817.79
in general payments reported to CMS, 2019-2025
25 companies · $237 in 2025
The $237 reported for 2025 was less than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $330 · 2020: $238 · 2021: $512 · 2022: $646 · 2023: $441 · 2024: $415 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,093.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,092.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $430.32 | 2019-2024 | |
| Glaxosmithkline, LLC. | $405.41 | 2021-2024 | Nucala |
| Medtronic, INC. | $376.62 | 2021-2025 | Propel, Pteye Parathyroid Detection System |
| Genzyme Corporation | $329.08 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $274.36 | 2019-2024 | Dupixent |
| Aerin Medical INC. | $175.57 | 2020-2025 | |
| Integra Lifesciences Corporation | $147.64 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Stryker Corporation | $138.07 | 2019-2021 | |
| Acclarent, INC | $96.63 | 2019-2022 | |
| Olympus America INC. | $86.09 | 2021 | |
| Kls-Martin L.P. | $53.25 | 2021-2022 | |
| Inspire Medical Systems, INC. | $41.26 | 2023-2025 | Inspire |
| Acera Surgical, INC. | $33.92 | 2024 | Restrata Wound Matrix |
| Kerecis Limited | $30.97 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Acell, INC. | $28.83 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $27.68 | 2023 | |
| Reddress USA, INC. | $21.30 | 2024 | |
| Novartis Pharmaceuticals Corporation | $19.58 | 2019 | |
| Hologic Sales and Service, LLC | $18.43 | 2023 | Coolseal Generator |
| Celgene Corporation | $16.92 | 2024 | Reblozyl |
| Smith+Nephew, INC. | $15.55 | 2025 | Tula |
| Convatec INC. | $13.84 | 2025 | |
| Arbor Pharmaceuticals, INC. | $12.71 | 2019 | |
| Medtronic USA, INC. | $12.14 | 2019 | |
| Bolder Surgical LLC | $11.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Peller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.